• High Quality API Mosapride Citrate Dihydrate Powder CAS 156925-25-6
  • High Quality API Mosapride Citrate Dihydrate Powder CAS 156925-25-6
  • High Quality API Mosapride Citrate Dihydrate Powder CAS 156925-25-6
  • High Quality API Mosapride Citrate Dihydrate Powder CAS 156925-25-6
  • High Quality API Mosapride Citrate Dihydrate Powder CAS 156925-25-6
  • High Quality API Mosapride Citrate Dihydrate Powder CAS 156925-25-6

High Quality API Mosapride Citrate Dihydrate Powder CAS 156925-25-6

Powder: Yes
Customized: Non-Customized
Certification: USP
Suitable for: Adult
State: Powder
Purity: >99%
Customization:
Diamond Member Since 2019

Suppliers with verified business licenses

Rating: 4.9/5

Basic Info.

Model NO.
201905140313
Name
Mosapride Citrate Dihydrate
Other Names
Mosapride Citrate Dihydrate Capsules
Other Name
Mosapride Citrate Dihydrate Powder
CAS
156925-25-6
Einecs
0
Molecular Formula
C27h37clfn3o12
Molecular Weight
650.05
Content
98%
Color
White
Form
Powder
Type
API
Grade
Pharma
MOQ
10g
Storage
Cool Dry Place
Shelf Life
2 Years
Transport Package
Foil Bag
Specification
99%
Trademark
TGYBIO
Origin
China
HS Code
2019051403
Production Capacity
20kg/Month

Product Description

High Quality API Mosapride Citrate Dihydrate Powder CAS 156925-25-6
High Quality API Mosapride Citrate Dihydrate Powder CAS 156925-25-6
Citrate moser will benefit (Mosapride Citrate, MC) promote power for the fourth generation of gastrointestinal medicine, is a potent selectivity of 5 - HT4 agonists, through 5 - excited myenteric plexus HT4 receptors, stimulate acetylcholine release, strengthen the stomach and duodenum movement, clinical used in functional dyspepsia, gastroesophageal reflux disease, diabetic gastroparesis, partial nephrectomy in patients with gastric diseases such as gastric dysfunction. Common adverse reactions include diarrhea, abdominal pain, dry mouth, rash, tiredness and headache. At present, its market products are only tablets, dispersible tablets, capsules and other oral dosage forms.

Moxapride citrate is similar to cisapride, both of which are benzodiamide derivatives. By stimulating 5-ht4 receptors in intestinal muscle plexus, moxapride citrate can increase the release of acetylcholine in nerve endings and promote gastrointestinal motility and gastric empty.it has the advantages of strong receptor selectivity, good pharmacokinetics, selective action on digestive tract and small dose. Electrophysiological studies have shown that it has no effect on extending the action potential duration of isolated ventricular muscle and bradycardia fibers, so it has better safety.

High Quality API Mosapride Citrate Dihydrate Powder CAS 156925-25-6

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Diamond Member Since 2019

Suppliers with verified business licenses

Rating: 4.9/5
Terms of Payment
LC, T/T, D/P, PayPal, Western Union, Small-amount payment
International Commercial Terms(Incoterms)
FOB, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, FCA, EXW, Others